Announcements Trials
Browse Landscape

Phase

Phase NA 23Phase 1 22Phase 2 16Phase 1/2 15Phase EARLY_PHASE1 12Phase 3 8Phase 4 6Phase 2/3 3

Status

Completed 22Recruiting 9Unknown 8Not yet recruiting 6Withdrawn 3Terminated 2Active not recruiting 2

Sponsor Class

OTHER 4NETWORK 1INDUSTRY 1

Study Type

Interventional 6

Sponsor

Cancer Type

Plasma cell 6Lymphoid 1Genitourinary 1

Conditions

Breast Neoplasms 20Carcinoma, Hepatocellular 8Stomach Neoplasms 6Multiple Myeloma 6Colorectal Neoplasms 5Uterine Cervical Neoplasms 4Neoplasms 4Endometrial Neoplasms 4Small Cell Lung Carcinoma 3Recurrence 3Prostatic Neoplasms 3Ovarian Neoplasms 3Melanoma 3Lung Neoplasms 3Febrile Neutropenia 3Carcinoma, Non-Small-Cell Lung 3Waldenstrom Macroglobulinemia 2Venous Thromboembolism 2Skin Neoplasms 2Pancreatic Neoplasms 2Pancreatic Cancer Non-resectable 2Obesity 2Neoplasm Metastasis 2Lymphoma, B-Cell 2Leukemia, Lymphocytic, Chronic, B-Cell 2Hepatitis B 2Hematologic Neoplasms 2Gastric / Gastroesophageal Junction Adenocarcinoma 2Anemia 2Acute Kidney Injury 2

Interventions

zanubrutinib 1tocilizumab 1talquetamab 1isatuximab 1ibrutinib 1Renal Dialysis 1Lenalidomide 1Hemodiafiltration 1Drug Therapy 1Dexamethasone 1Dasatinib 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 4 × Not yet recruiting × Multiple Myeloma × Clear all
NCT07609940 2026-05-27

POPLIN

Regeneron Pharmaceuticals

Phase 4 Not yet recruiting
30 enrolled
Plasma cell

Cytokine Release Syndrome, Multiple Myeloma

NCT07474961 2026-03-16

BLOOD-dose

Rigshospitalet, Denmark

Phase 4 Not yet recruiting
400 enrolled
LymphoidPlasma cell

Waldenstrom Macroglobulinemia, Multiple Myeloma

NCT07334535 2026-01-13

Isa-VRD in TIE HRMM

Peking Union Medical College Hospital

Phase 4 Not yet recruiting
117 enrolled
Plasma cell

Multiple Myeloma

NCT07191379 2025-09-24

SCILLA

Odense University Hospital

Phase 4 Not yet recruiting
50 enrolled
Plasma cell

Multiple Myeloma

NCT05944783 2025-02-12

BE-Dasatinib

Centro de Atencion e Investigacion Medica

Phase 4 Not yet recruiting
46 enrolled
Plasma cell

Multiple Myeloma

NCT05429515 2022-06-23

Effect of HFR-SUPRA in the Treatment of Multiple Myeloma-related Acute Kidney Injury

Peking Union Medical College Hospital

Phase 4 Not yet recruiting
50 enrolled
GenitourinaryPlasma cell

Multiple Myeloma, Acute Kidney Injury

Data powered by HemOnc (CC BY 4.0) Colophon âš¡